We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Intravacc yesterday announced a partnership with Leiden University Medical Center (LUMC) to develop and evaluate a new nasal spray corona vaccine in a clinical phase-I/II study.